Cramer Rosenthal McGlynn’s Astera Labs ALAB Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,000	Closed	-$74.2K	–	113
2024 Q1	$74.2K	Buy	+1,000	New	+$74.1K	﹤0.01%	104

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return

Cramer Rosenthal McGlynn's ALAB Position: Q2 2024 in Review

Cramer Rosenthal McGlynn sold out of Astera Labs (ALAB) in Q2 2024, closing a stake of 1,000 shares — an estimated $74.2K sold.

Cramer Rosenthal McGlynn first reported a position in ALAB in Q1 2024 and held it in 1 quarter. The position peaked at $74.2K in Q1 2024. 146 funds tracked by Wall St. Rank hold ALAB as of Q2 2024.

Cramer Rosenthal McGlynn reported no remaining Astera Labs position as of Q2 2024 after selling out during the quarter.
Cramer Rosenthal McGlynn sold 1,000 Astera Labs shares in Q2 2024, an estimated $74.2K.
Cramer Rosenthal McGlynn first reported a position in Astera Labs in Q1 2024 and held it in 1 quarter.
Cramer Rosenthal McGlynn's Astera Labs position peaked at $74.2K in Q1 2024.
146 funds tracked by Wall St. Rank held Astera Labs as of Q2 2024.

Based on Cramer Rosenthal McGlynn's 13F filing for Q2 2024, filed 13 Aug 2024.